Patents by Inventor John W. Blasecki

John W. Blasecki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6911431
    Abstract: Disclosed are methods of inhibiting neovascularization in a subject by administering to the subject a pharmaceutical preparation of R?-Glu-Trp-R?.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: June 28, 2005
    Assignee: Melmotte, Inc.
    Inventors: Lawrence R. Green, John W. Blasecki
  • Patent number: 6096713
    Abstract: Disclosed are methods of inhibiting neovascularization in a subject by administering to the subject a pharmaceutical preparation of R'-Glu-Trp-R".
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: August 1, 2000
    Assignee: Cytran, Inc.
    Inventors: Lawrence R. Green, John W. Blasecki
  • Patent number: 5902790
    Abstract: Disclosed are methods of inhibiting neovascularization in a subject by administering to the subject a pharmaceutical preparation of R'-Glu-Trp-R".
    Type: Grant
    Filed: March 13, 1996
    Date of Patent: May 11, 1999
    Assignee: Cytran, Inc.
    Inventors: Lawrence R. Green, John W. Blasecki
  • Patent number: 5093327
    Abstract: There are disclosed pharmaceutical compositions containing polyoxoanions, methods of using them alone or in combination with other compounds, such as AZT and Poly-I:C for the treatment of retroviruses. Also disclosed are novel polyoxoanions.
    Type: Grant
    Filed: July 16, 1991
    Date of Patent: March 3, 1992
    Assignee: Du Pont Merck Pharmaceutical Company
    Inventors: Peter J. Domaille, John W. Blasecki
  • Patent number: 5051414
    Abstract: There are disclosed pharmaceutical compositions containing polyoxoanions, methods of using them alone or in combination with other compounds, such as AZT and Poly-I:C for the treatment of retroviruses. Also disclosed are novel polyoxoanions.
    Type: Grant
    Filed: August 3, 1989
    Date of Patent: September 24, 1991
    Assignee: Dupont Merck Pharmaceutical Company
    Inventors: Peter J. Domaille, John W. Blasecki